问题 › 竞争对手正在抢走我们的客户 › 医疗服务提供商
归因生命流向竞争对手，更常见的是定位问题而非报销问题，二者需要相反的应对。 这个问题在医疗服务提供商身上的版本并不通用。已对38,000 lives承担 downside risk，却缺少定价所需的分次成本数据——因此忽略分次成本的答案必然错误。分析必须从 payer mix 和 panel size 而非收入开始。
归因生命流向竞争对手，更常见的是定位问题而非报销问题，二者需要相反的应对。 这个问题在医疗服务提供商身上的版本并不通用。已对38,000 lives承担 downside risk，却缺少定价所需的分次成本数据——因此忽略分次成本的答案必然错误。分析必须从 payer mix 和 panel size 而非收入开始。
当竞争对手开始赢得归因生命时，组织内给出的第一解释总是报销。这偶尔正确。更常见的情况是竞争对手在某一领域围绕分次成本做出了更窄的承诺，并在其中击败你，这在医疗总监或 CFO 看来像是报销，因为那是合同转移前最后谈判的条款。
区别很重要，因为应对方式互不相容。如果真是报销问题，你要么匹配费率并重新定价整个基于价值的合同簿，要么接受该细分市场的流失。如果是定位问题，匹配费率就是在资助他们的优势，同时破坏每个提供商的贡献。
判断方法不 glamourous：记录最近二十个流失归因生命的原因，并分段。报销问题会均匀出现。定位问题则会聚集。
这三者同时出现才是标志。单独一个通常指向其他问题。
✓ 流失的归因生命集中在一种 payer mix 或一种 episode type，而非均匀分布在整个 panel
✓ 医疗总监或 CFO 要求获得调整合同费率的权限，而不是要求不同的分次成本证明
✓ 竞争对手规模更小，在基于价值的合同中承接的 episode 更具体
通常会让情况更糟的做法。 匹配报销费率却保留原有定位，结果既损失每个提供商的贡献，又在论证中落败。
It is for you if you run or finance a healthcare provider and losses concentrate in one segment or one use case rather than spreading evenly. It is the situation where the numbers are available but nobody has put them in an order that produces a decision.
It is not for you if Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Below is an excerpt from a real run of this analysis on 一家医疗服务提供商. It is a sample profile rather than a customer, and it is engine output translated from English — this is the format you get, on your own numbers.
The subject is Cedar Ridge Health Partners, a sample company profile used for testing rather than a customer — 38,000 attributed lives under value-based contracts.
Excerpt from a real Percision run · Quick Market Scan · sample company profile
The move. Sell coordinated care bundles directly to self-insured employers using existing clinic density and ASC capacity.
The leak it closes. Bypasses commercial payer take-rate (estimated 15–20% of premium) and prior-authorization friction, reducing denial leakage on these lives to near zero
The assumption it rests on. At least two of the five largest self-insured employers in the two metros will sign a 3-year direct contract within 18 months — the engine put the probability at 0.7.
| Investment required | $2M over 36 months ($800K Year 1, $700K Year 2, $500K Year 3) |
| Expected return | 6.0–9.0× on $2M investment |
| Revenue, year 1 | $0 incremental (pilot setup and first contract negotiations) |
| Revenue, year 2 | $4–6M incremental (2–3 employer contracts, 4,000–6,000 covered lives) |
| Revenue, year 3 | $12–18M incremental (5 employer contracts, 10,000–15,000 covered lives) |
| Exit criteria | Terminate pilot and redeploy 4 FTEs if fewer than 2 employer contracts signed by Month 18 OR if operating margin on employer channel falls below 6% for two consecutive quarters |
This is one move out of a full analysis. Read a complete report — every page, no email required.
This question routes to 竞争基准与定位, one of 29 engagements the platform runs. For 医疗服务提供商 it works through cost per episode, payer mix, panel size and contribution per provider, then produces the sequence rather than a list of options — which move first, what it funds, and the observation that would say the sequence is wrong.
You watch the analysis get built before paying anything. 在此阅读完整报告 if you would rather see the depth first.
只有当你能以他们的价格服务该细分市场并仍有盈利，且愿意为已支付更高费用的客户重新定价时才可。选择性匹配通常是无法兑现的承诺，一旦市场注意到就会失效。
靠具体性，而非广度。资金更雄厚的对手可以在 everywhere 花更多钱，却无法在某一处比你更专注，这也是为什么收窄承诺通常胜过扩展功能集。
那诚实的答案就是带时间表和成本的产品决策，而不是营销回应。最坏的结果是花一年时间做 messaging，却无法弥合 messaging 无法弥合的差距。
Materially, yes. Downside risk has been accepted on 38,000 lives without the cost-per-episode data needed to price it — which changes both the diagnosis and the order of the fixes. The metrics that decide it here are cost per episode, payer mix, panel size, and an answer built on industry-general benchmarks will usually point at the wrong one first.
Less than most people expect. Your last twelve months of revenue and cost split the way you already split it, plus whatever you hold on cost per episode and payer mix. The analysis is explicit about what it is assuming where your data stops, which is more useful than waiting for numbers you may never have.
Percision is the wrong tool if you already know the answer and only need execution capacity, or if the business is pre-revenue — then the constraint is evidence about the market, not analysis of your own figures. Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library. Also wrong if you need facilitation, politics, or someone to sit with a lender or buyer. Those are human jobs.
Percision is not a lawyer, tax advisor, auditor, licensed appraiser, clinical or regulatory filer, or an AI implementation shop. It does not do HR casework, creative-only brand work, or impersonate a named consulting firm. It is a strategy analysis engine — not a template library.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.
English · Español · Deutsch · Português · Français · Italiano · Nederlands · 日本語 · 한국어 · 中文 · Polski · Svenska · Türkçe · العربية · Tiếng Việt · ไทย · हिन्दी · עברית